Newly uncovered FDA emails indicate significant disparities in safety monitoring of COVID-19 vaccines. Consistent alerts for the Janssen vaccine contrasted sharply with a lack of alerts for Pfizer and Moderna, focusing on serious adverse events including deep vein thrombosis. Despite over 1.4 million adverse reports in VAERS, critical risks like myocarditis and pericarditis in mRNA vaccines went largely unflagged. This reliance on a singular data analysis method raises concerns among critics about transparency and the adequacy of the safety monitoring process throughout the vaccination campaign.
‘The consistent alerts for the Janssen vaccine contrasted sharply with a lack of alerts for Pfizer and Moderna vaccines, underscoring significant oversight gaps.’
‘Over 1.4 million adverse event reports failed to detect recognized risks such as myocarditis and pericarditis, raising concerns over monitoring effectiveness.’
Collection
[
|
...
]